Market Overview

CAR T Cell Therapy Market Global Trends, Growth Drivers, Targeted Antigens Opportunities and Forecast to 2028

Share:

CAR T Cell Therapy Market Global Trends, Growth Drivers, Targeted Antigens Opportunities and Forecast to 2028

PR Newswire

PUNE, India, August 3, 2018 /PRNewswire/ --

ReportsnReports.com adds CAR T Cell Therapy Market, Global Forecast by Regions, Targeted Antigens, Clinical Trials/Study and Companies research report of 159 pages to its online industry intelligence store.

CAR T Cell Therapy market is expected to grow with a CAGR of over 46 percent in the forecast period. Year 2017 has created new milestone for the oncology patients as FDA approved the first two CD19-targeted (Chimeric Antigen Receptor) CAR T cell therapies developed by Novartis and Gilead Sciences/Kite Pharma in the United States. These two approvals will certainly help to boost the global CAR T cell therapy market as more players are looking this big opportunities to enter the market place. At present over 200 CAR T clinical trials are running or completed across various parts of the world.  

Rising number of adults and children developing cancer, increasing government initiatives for promoting research for cell therapy in cancer and rising number of clinical trials globally are some of the key drivers for the global CAR T Cell therapy market; however high cost of CAR T cell therapy treatment and regulatory challenges are key inhibitors for this market.

Place a direct purchase order on this report at http://www.reportsnreports.com/purchase.aspx?name=1592579.

Key Companies covered: Novartis, Gilead Sciences (Kite Pharma), Celgene Corporation (Juno Therapeutics) & Celyad

The report "CAR T Cell Therapy Market Global Forecast by Regions (North America, Europe, Asia Pacific, Latin America, Middle East, Africa), Targeted Antigens (CD19, CD20, GD2, CD22, CD30, CD33, HER2, MESO, EGFRvII, Others) Clinical Trials/Study (CD19, CD20, GD2, CD22, CD30, CD33,HER1, HER2, MESO, EGFRvII) Companies (Novartis,Gilead Sciences (Kite Pharma), Celgene Corporation (Juno Therapeutics), Celyad)" provides a detailed and comprehensive insight of the global CAR T cell therapy market.

This report studies the Global CAR T cell therapy market from 2 key view points by CAR T cell therapy market and CAR T cell therapy studies. Market segments are further studied by geographical regions and targeted antigens whereas CAR T cell therapy studies by targeted antigens globally and China specific. The report provides a complete analysis of the key Growth Drivers and Challenges, SWOT analysis, market, and their projections for the upcoming years (2028)

Inquire for a discount on this report at USD 2390 (Single User License) at https://www.reportsnreports.com/contacts/discount.aspx?name=1592579.

The report has been analyzed from 9 major viewpoints: 

  1. Targeted Antigen - Global CAR T Cell Therapy Market
  2. Regional CAR T Cell Therapy Market
  3. Global - CAR T Cell Therapy Clinical Trials/Study
  4. China CAR T Cells Clinical Trials Details
  5. CAR T Cell Therapy SWOT Analysis
  6. The Regulation in CAR T Cell Therapy
  7. Global - IPO/Investment/Funding/Partnership in CAR T Cell Therapy Market
  8. Growth Drivers and Challenges
  9. Key CAR T companies Initiatives and Financial Insight


Targeted Antigens - Global CAR T Cell Therapy Market & Forecast: CD19, CD20, GD2, CD22, CD30, CD33, HER2, MESO, EGFRvII

Regional CAR-T Cell Therapy Market: North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Global - CAR T Cell Therapy Clinical Trials/Study: CD19, CD20, GD2, CD22, CD30, CD33, HER1, HER2, EGFRvII MESO

Complete report available with table of contents at https://www.reportsnreports.com/reports/1592579-car-t-cell-therapy-market-global-forecast-by-regions-targeted-antigens-clinical-trials-study-companies.html.

China CAR T Cells Clinical Trials Details: 

By Cities CAR T Cells Clinical Trials

CD19 Directed CAR T Cells Clinical Trials

Non-CD19 Directed CAR T Cells Clinical Trials

Solid Tumors CAR T Cells Clinical Trials

Client can purchase this report in sections through Purchase by Chapter Tab given above

The Regulation in CAR T Cell Therapy: United States, European Union & China

IPO/Investment/Funding/Partnership in CAR T Cell Therapy Market: Venture Capital Investment, Initial Public Offerings, Strategic Partnerships/Deals, Key CAR T Technology Deals

Major Points from Table of Contents: 

1.    Executive Summary

2.    Global Chimeric Antigen Receptor (CAR)-T cell Therapy Market

3.    Market Share - CAR-T Cell Therapy

4.    Targeted Antigen Market

5.    Geographical CAR-T Cell Therapy Market (2016 -2026)

6.    Global - CAR-T Cell Clinical Trials/Study

7.    China CAR-T Cells Clinical Trials Details

8.    CAR-T Cell Therapy SWOT Analysis

9.    Regulation in CAR-T Cell Therapy

10.    IPO/Investment/Funding/Partnership in CAR-T Cell Therapy Market

11.    Growth Drivers

12.    Challenges

13.    Novartis

14.    Gilead Sciences (Kite Pharma)

15.    Celgene Corporation (Juno Therapeutics)

16.    Celyad

Explore More Related Reports on Medical Devices Market Research: 

High Intensity Focused Ultrasound (HIFU) Patients Treated by Indication, Product Analysis of 20 Manufacturers, Deals & Numbers by Region

Global Medical/Diagnostic Imaging Market (X-Ray, Ultrasound, CT, MRI & Nuclear Imaging): Industry Analysis & Outlook (2018-2022)

About Us: 

ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Contact Us:

Hrishikesh Patwardhan

Tower B5, office 101,

Magarpatta SEZ,

Hadapsar, Pune-411013.

Tel: +1-888-391-5441

E-mail: sales@reportsandreports.com


SOURCE ReportsnReports

View Comments and Join the Discussion!